PharmaLytica Expo to aid in chalking out pharma industry’s $130 Billion growth story by 2030
The 8th edition of PharmaLytica Expo opened its doors to industry professionals at the Bombay Exhibition Centre, Mumbai today. The event had a grand opening in the presence of key dignitaries Mr. K. G. Ananthakrishnan, Director General – OPPI, Mr. Sudarshan Jain, Secretary General, Indian Pharmaceutical Alliance, Mr. Chakravarthi AVPS Garu, Global Ambassador – World Packaging Organisation & Director on board for Pharmaceutical Export Promotion Council and Mr Rahul Deshpande, Group Director, Informa Markets in India. The annual three-day exhibition provides high-profile business matchmaking and networking opportunities for all industry professionals, including domain stalwarts, pharma leaders, technical heads & plant heads, medical heads & scientists, marketing & strategy leaders, R&D heads and technocrats, engineering & production professionals, purchase & packaging professionals, Regulatory Affairs professionals and others.
Amongst over 300 brands showcasing their latest developments and 30 conference speakers, the expo is anticipating over 7000 trade visitors over the three days. The key players include Shimadzu, Thermolab, Agilent, Saksham Scientific, SRICO, Newtronics, Mack Pharmatech, Sanosil Biotech, Toshvin Analytical, PCI Analytics, Sanitt Equipment, Elmach, Parle Global among many others. The event is supported by the Pharmaceuticals Export Promotion Council of India, IDMA and CiPi
On the occasion of the 8th edition of PharmaLytica, Mr. Yogesh Mudras, Managing Director, Informa Markets, India said, “Over these three days, the PharmaLytica Expo will facilitate one-to-one meetings for industry stalwarts’ and trade professionals to exchange ideas, grow business, display innovation and technology, skills, experience, and thoughts and trigger novel ideas on manufacturing. Today pharma is recognized as a well-entrenched sector for our country’s economy and is anticipated to grow threefold in the decade. While it is expected to be a $65 billion industry by 2024, with weighty contributions toward generics, the pharmaceutical industry is all set to further extend its R&D capabilities and offer cutting-edge products in a post-pandemic world.”
“We are sure thatwith the breadth of innovation and insights on offer at the expo, our buyer and seller community will be armed with new concepts, ideas and solutions to help them design and manufacture ever more innovative solutions,” he further added.
Speaking at the inauguration, Mr. KG Ananthakrishnan, DG – OPPI said, “The pharmaceutical market is set to grow from its current levels of $50Bn to US$130Bn by 2030 growing at a CAGR of 12.3%. This target can be achieved by having a global outlook looking at Asian geographies along with existing completive advantage in various industries, favorable factors of production, conducive business environment, and incentivized government policies. Along with these factors, Digital transformation across the entire value chain is vital for enhanced patient care, greater transparency, cost-effectiveness, improved production and drug development. Latest technologies such as artificial intelligence (AI), AR/VR, Block Chain, machine learning (ML) and additive manufacturing are helping pharma companies improve the R&D process, conducting clinical tests in less time and adding innovation to the productswhile improving compliance and efficiencies in manufacturing and inventory management.”
The healthcare industry has raised the quality standards & is also moving swiftly towards digitalisation. PharmaLytica Conference 2022 is discussing key topics like Challenges and opportunities in moving towards digitalization, strategies for maintaining a global supply chain in a constrained environment and new analysis methods for the optimization of processes in the laboratory thereby transforming labs into smart technological labs. The 2-day conference is an exclusive invite-only event and will see key industry stalwarts’ strategies to charter the next phase of growth in pharma. The conference also deliberated on topics such as API, machinery and manufacturing, lab & analytical, QR Code, supply chain, packaging and labelling, AI, IoT, Blockchain, Bigdata in Pharma, Pharma Supply Chain, Packaging & Labelling, Serialization and Track &Trace. The highly resourceful exhibition also delivered important aspects of global pharma manufacturing.
About Informa Markets
Informa Markets creates platforms for industries and specialist markets to trade, innovate and grow. Our portfolio is comprised of more than 550 international B2B events and brands in markets including Healthcare & Pharmaceuticals, Infrastructure, Construction & Real Estate, Fashion & Apparel, Hospitality, Food & Beverage, and Health & Nutrition, among others. We provide customers and partners around the globe with opportunities to engage, experience and do business through face-to-face exhibitions, specialist digital content and actionable data solutions. As the world’s leading exhibitions organiser, we bring a diverse range of specialist markets to life, unlocking opportunities and helping them to thrive 365 days of the year. For more information, please visit www.informamarkets.com
About Informa Markets and our business in India
Informa Markets is owned by Informa PLC, a leading B2B information services group and the largest B2B Events organiser in the world. Informa Markets in India (formerly UBM India) is India’s leading exhibition organizer, dedicated to help specialist markets and customer communities, domestically and around the world to trade, innovate and grow through exhibitions, digital content & services, and conferences & seminars. Every year, we host over 25 large scale exhibitions, 40 conferences, along with industry awards and trainings across the country; thereby enabling trade across multiple industry verticals. In India, Informa Markets has offices in Mumbai and New Delhi.
